Critically analyse the implementation of an innovation in a healthcare setting, using a change model of your choice which should include the strategic and operational management and leadership issues.

For this summative assessment, you are required to submit a poster with an audio recording. You are required to:

• Critically analyse the implementation of an innovation in a healthcare setting.
• Use a Change Model of your choice. 
• Ensure your discussion includes the strategic and operational management and leadership issues linked to the implemented change.

Module Learning Outcomes

There is no specified Word Count for this assignment, and it is worth 50% of the total marks for this module.

Your work will be assessed on the following 3 Module Learning Outcomes (so ensure these are covered in your PowerPoint and Audio):

1. Critique methods of quality improvement and evaluate approaches from the healthcare perspective.
2. Have a critical understanding of models of change management and project planning approaches to deliver change that supports the strategic objectives of the organisation.
3. Demonstrate a clear understanding of the strategic and operational management and leadership issues relating to quality improvement, innovation, and change.

Answer

Abstract

Artificial intelligence (AI) is a field that is growing very quickly and is rapidly transforming the health care industry. AI holds immense promise for improving patient care and outcomes. However, the integration of AI into medical practice is not without its challenges. Concerns regarding patient safety, algorithmic bias, and data privacy necessitate a robust regulatory framework to ensure the responsible and ethical use of AI in healthcare (Wani et al., 2022). 

In this analysis, we examine all of the current global policies in place, paying particular attention to important initiatives like as the AI Act of the European Union and the regulations of the World Health Organisation (WHO). We also look at national and international standards, such as those established by the US Food and Drug Administration (FDA), the UK Medicines and Healthcare products Regulatory Agency (MHRA), and the Australian Therapeutic Goods Association (TGA) (Saw and Ng, 2022).